Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) have received a consensus rating of “Moderate Buy” from the twenty-four research firms that are currently covering the stock, Marketbeat reports. Five research analysts have rated the stock with a hold recommendation, eighteen have issued a buy recommendation and one has assigned a strong buy […]

Verizon Communications Inc. (NYSE:VZ – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the sixteen research firms that are currently covering the company, Marketbeat.com reports. Seven investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company. The average 12-month price objective […]

Symbotic Inc. (NASDAQ:SYM – Get Free Report) has received an average recommendation of “Moderate Buy” from the fourteen research firms that are currently covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and ten have issued a buy rating on the […]

Shares of Magna International Inc. (NYSE:MGA – Get Free Report) (TSE:MG) have earned an average recommendation of “Hold” from the nineteen analysts that are currently covering the company, MarketBeat reports. One analyst has rated the stock with a sell rating, twelve have assigned a hold rating and six have assigned a buy rating to the […]

JPMorgan Chase & Co. (NYSE:JPM) has earned an average rating of “Moderate Buy” from the eighteen ratings firms that are covering the company, MarketBeat reports. Seven analysts have rated the stock with a hold recommendation and eleven have given a buy recommendation to the company. The average 12 month price objective among brokers that have […]

Shares of Freshworks Inc. (NASDAQ:FRSH – Get Free Report) have earned an average rating of “Moderate Buy” from the fourteen research firms that are presently covering the stock, MarketBeat Ratings reports. Five equities research analysts have rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The average […]

HCI Group, Inc. (NYSE:HCI – Get Free Report) has earned a consensus recommendation of “Buy” from the five ratings firms that are covering the stock, Marketbeat Ratings reports. Five equities research analysts have rated the stock with a buy rating. The average 1 year price target among analysts that have covered the stock in the […]

Shares of GE Vernova Inc. (NYSE:GEV – Get Free Report) have been given an average rating of “Moderate Buy” by the twenty-one research firms that are presently covering the company, Marketbeat.com reports. Three investment analysts have rated the stock with a hold recommendation, sixteen have given a buy recommendation and two have issued a strong […]

Shares of West Fraser Timber Co. Ltd. (NYSE:WFG – Get Free Report) have been assigned a consensus rating of “Buy” from the five analysts that are currently covering the company, Marketbeat Ratings reports. Four research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. […]

Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) have received a consensus rating of “Buy” from the eight ratings firms that are covering the company, MarketBeat Ratings reports. Seven investment analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 1 […]

Shares of Hancock Whitney Co. (NASDAQ:HWC – Get Free Report) have been given an average recommendation of “Moderate Buy” by the nine ratings firms that are presently covering the stock, Marketbeat Ratings reports. Three analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average […]

Reliance, Inc. (NYSE:RS – Get Free Report) has received a consensus rating of “Hold” from the five research firms that are covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and two have assigned a buy rating to the company. The average […]

Shares of Janux Therapeutics, Inc. (NASDAQ:JANX – Get Free Report) have been given a consensus rating of “Moderate Buy” by the nine research firms that are covering the company, MarketBeat.com reports. One research analyst has rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average 1 […]

Amicus Therapeutics, Inc. (NASDAQ:FOLD – Get Free Report) has earned an average recommendation of “Moderate Buy” from the nine research firms that are covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average twelve-month price objective […]

Shares of Reddit, Inc. (NYSE:RDDT – Get Free Report) have earned a consensus rating of “Moderate Buy” from the seventeen research firms that are presently covering the company, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, six have assigned a hold recommendation, nine have issued a buy recommendation and one […]

JMP Securities reaffirmed their market outperform rating on shares of Bicycle Therapeutics (NASDAQ:BCYC – Free Report) in a research report report published on Monday, Benzinga reports. JMP Securities currently has a $32.00 price target on the stock. A number of other equities analysts have also weighed in on BCYC. Needham & Company LLC reiterated a […]

CME Group Inc. (NASDAQ:CME – Get Free Report) has been given an average recommendation of “Reduce” by the eleven research firms that are covering the company, Marketbeat Ratings reports. Four investment analysts have rated the stock with a sell recommendation, four have assigned a hold recommendation and three have given a buy recommendation to the […]

Casey’s General Stores, Inc. (NASDAQ:CASY – Get Free Report) has been given an average recommendation of “Moderate Buy” by the ten brokerages that are currently covering the company, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 1-year […]

Longboard Pharmaceuticals (NASDAQ:LBPH – Get Free Report) had its price target lifted by research analysts at HC Wainwright from $60.00 to $80.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The firm currently has a “buy” rating on the stock. HC Wainwright’s price target would suggest a potential upside of […]